Diagnostic Testing Fund – Adult Oncology: Brain/CNS Tumors

This fund supports adults with suspected brain or spinal tumors by providing access to critical diagnostic testing — including genetic testing and tumor marker analysis — to help classify the tumor and inform treatment planning. For conditions like glioblastoma or meningioma, advanced testing such as genomic profiling may be needed to determine eligibility for targeted therapies or clinical trials, which can be especially important for individuals facing aggressive or rare tumor types.